Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 234

1.

Progressive metaplastic and dysplastic changes in mouse pancreas induced by cyclooxygenase-2 overexpression.

Colby JK, Klein RD, McArthur MJ, Conti CJ, Kiguchi K, Kawamoto T, Riggs PK, Pavone AI, Sawicki J, Fischer SM.

Neoplasia. 2008 Aug;10(8):782-96.

2.

Identification and manipulation of biliary metaplasia in pancreatic tumors.

Delgiorno KE, Hall JC, Takeuchi KK, Pan FC, Halbrook CJ, Washington MK, Olive KP, Spence JR, Sipos B, Wright CV, Wells JM, Crawford HC.

Gastroenterology. 2014 Jan;146(1):233-44.e5. doi: 10.1053/j.gastro.2013.08.053. Epub 2013 Aug 30.

3.

Acinar-to-ductal metaplasia accompanies c-myc-induced exocrine pancreatic cancer progression in transgenic rodents.

Grippo PJ, Sandgren EP.

Int J Cancer. 2012 Sep 1;131(5):1243-8. doi: 10.1002/ijc.27322. Epub 2012 Jan 11.

4.

The c-myc and PyMT oncogenes induce different tumor types in a somatic mouse model for pancreatic cancer.

Lewis BC, Klimstra DS, Varmus HE.

Genes Dev. 2003 Dec 15;17(24):3127-38. Epub 2003 Dec 17.

5.

Inactivation of Smad4 accelerates Kras(G12D)-mediated pancreatic neoplasia.

Kojima K, Vickers SM, Adsay NV, Jhala NC, Kim HG, Schoeb TR, Grizzle WE, Klug CA.

Cancer Res. 2007 Sep 1;67(17):8121-30.

6.

Hypothetical progression model of pancreatic cancer with origin in the centroacinar-acinar compartment.

Esposito I, Seiler C, Bergmann F, Kleeff J, Friess H, Schirmacher P.

Pancreas. 2007 Oct;35(3):212-7.

PMID:
17895840
7.

Preinvasive duct-derived neoplasms in pancreas of keratin 5-promoter cyclooxygenase-2 transgenic mice.

Müller-Decker K, Fürstenberger G, Annan N, Kucher D, Pohl-Arnold A, Steinbauer B, Esposito I, Chiblak S, Friess H, Schirmacher P, Berger I.

Gastroenterology. 2006 Jun;130(7):2165-78.

PMID:
16762637
8.

Early requirement of Rac1 in a mouse model of pancreatic cancer.

Heid I, Lubeseder-Martellato C, Sipos B, Mazur PK, Lesina M, Schmid RM, Siveke JT.

Gastroenterology. 2011 Aug;141(2):719-30, 730.e1-7. doi: 10.1053/j.gastro.2011.04.043. Epub 2011 Apr 28.

PMID:
21684285
9.

The transcription factor ATF3 acts as an oncogene in mouse mammary tumorigenesis.

Wang A, Arantes S, Yan L, Kiguchi K, McArthur MJ, Sahin A, Thames HD, Aldaz CM, Macleod MC.

BMC Cancer. 2008 Sep 22;8:268. doi: 10.1186/1471-2407-8-268.

10.

Origin of pancreatic ductal adenocarcinoma from atypical flat lesions: a comparative study in transgenic mice and human tissues.

Aichler M, Seiler C, Tost M, Siveke J, Mazur PK, Da Silva-Buttkus P, Bartsch DK, Langer P, Chiblak S, Dürr A, Höfler H, Klöppel G, Müller-Decker K, Brielmeier M, Esposito I.

J Pathol. 2012 Apr;226(5):723-34. doi: 10.1002/path.3017. Epub 2012 Jan 17.

PMID:
21984419
11.

Establishment and characterization of human pancreatic adenocarcinoma cell line in tissue culture and the nude mouse.

Kong D, Nishino N, Shibusawa M, Kusano M.

Tissue Cell. 2007 Aug;39(4):217-23. Epub 2007 Jun 8.

PMID:
17560620
12.

Molecular changes in pancreatic cancer.

Buchholz M, Gress TM.

Expert Rev Anticancer Ther. 2009 Oct;9(10):1487-97. doi: 10.1586/era.09.107. Review.

PMID:
19828010
13.

CD97, CD95 and Fas-L clearly discriminate between chronic pancreatitis and pancreatic ductal adenocarcinoma in perioperative evaluation of cryocut sections.

Boltze C, Schneider-Stock R, Aust G, Mawrin C, Dralle H, Roessner A, Hoang-Vu C.

Pathol Int. 2002 Feb;52(2):83-8.

PMID:
11940212
14.

Therapeutic effect of CS-706, a specific cyclooxygenase-2 inhibitor, on gallbladder carcinoma in BK5.ErbB-2 mice.

Kiguchi K, Ruffino L, Kawamoto T, Franco E, Kurakata S, Fujiwara K, Hanai M, Rumi M, DiGiovanni J.

Mol Cancer Ther. 2007 Jun;6(6):1709-17.

15.

Gene expression alterations in the non-neoplastic parenchyma adjacent to infiltrating pancreatic ductal adenocarcinoma.

Fukushima N, Koopmann J, Sato N, Prasad N, Carvalho R, Leach SD, Hruban RH, Goggins M.

Mod Pathol. 2005 Jun;18(6):779-87.

16.

Activation of Notch signaling in tumorigenesis of experimental pancreatic cancer induced by dimethylbenzanthracene in mice.

Kimura K, Satoh K, Kanno A, Hamada S, Hirota M, Endoh M, Masamune A, Shimosegawa T.

Cancer Sci. 2007 Feb;98(2):155-62.

PMID:
17297654
17.

Maintenance of acinar cell organization is critical to preventing Kras-induced acinar-ductal metaplasia.

Shi G, DiRenzo D, Qu C, Barney D, Miley D, Konieczny SF.

Oncogene. 2013 Apr 11;32(15):1950-8. doi: 10.1038/onc.2012.210. Epub 2012 Jun 4.

18.

Silencing of GRP94 expression promotes apoptosis in pancreatic cancer cells.

Pan Z, Erkan M, Streit S, Friess H, Kleeff J.

Int J Oncol. 2009 Oct;35(4):823-8.

PMID:
19724918
19.

Ductal origin of pancreatic adenocarcinomas induced by conditional activation of a human Ha-ras oncogene in rat pancreas.

Ueda S, Fukamachi K, Matsuoka Y, Takasuka N, Takeshita F, Naito A, Iigo M, Alexander DB, Moore MA, Saito I, Ochiya T, Tsuda H.

Carcinogenesis. 2006 Dec;27(12):2497-510. Epub 2006 Jun 13.

PMID:
16774944
20.

Progression of pancreatic adenocarcinoma is significantly impeded with a combination of vaccine and COX-2 inhibition.

Mukherjee P, Basu GD, Tinder TL, Subramani DB, Bradley JM, Arefayene M, Skaar T, De Petris G.

J Immunol. 2009 Jan 1;182(1):216-24.

Supplemental Content

Support Center